BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Aligos Therapeutics\, Inc. (ALGS) investor events
X-WR-CALNAME:Aligos Therapeutics\, Inc. (ALGS) investor events
DESCRIPTION:Earnings calls and investor events for Aligos Therapeutics\, In
 c. (ALGS)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Aligos Therapeutics\, I
 nc. (ALGS)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:92242bcf-799b-41f7-b7c4-b36ddca6ae5f@equibles.com
DTSTAMP:20260617T190532Z
DTSTART;VALUE=DATE:20251106
DTEND;VALUE=DATE:20251107
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Aligos Therapeutics\, Inc. (ALGS) Earnings Call\, FY2025 Q3
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:5a251108-231d-4f3a-8621-3c4b8dab38bc@equibles.com
DTSTAMP:20260624T233126Z
DTSTART;VALUE=DATE:20251117
DTEND;VALUE=DATE:20251118
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Aligos Therapeutics\, Inc. (ALGS) Conference: Jefferies Global Heal
 thcare Conference in London
DESCRIPTION:Jefferies Global Healthcare Conference in London\nThe start tim
 e has not been announced.\nWebcast: https://wsw.com/webcast/jeff332/regist
 er.aspx?conf=jeff332&page=algs&url=https://wsw.com/webcast/jeff332/algs/18
 36549
END:VEVENT
BEGIN:VEVENT
UID:5f1c3c65-9809-4d59-ab39-83ad843ee7db@equibles.com
DTSTAMP:20260624T233126Z
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251204
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Aligos Therapeutics\, Inc. (ALGS) Conference: Piper Sandler Confere
 nce
DESCRIPTION:Piper Sandler Conference\nThe start time has not been announced
 .\nWebcast: https://investor.aligos.com/events/event-details/piper-sandler
 -conference
END:VEVENT
BEGIN:VEVENT
UID:4460f0d4-c5ac-415d-9700-0663d0144101@equibles.com
DTSTAMP:20260617T191111Z
DTSTART;VALUE=DATE:20260305
DTEND;VALUE=DATE:20260306
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Aligos Therapeutics\, Inc. (ALGS) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:3a9ba33c-fd4d-402b-9143-a3510aa506df@equibles.com
DTSTAMP:20260617T191104Z
DTSTART;VALUE=DATE:20260507
DTEND;VALUE=DATE:20260508
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Aligos Therapeutics\, Inc. (ALGS) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:65428f08-f11d-460b-99b1-1969236b9065@equibles.com
DTSTAMP:20260915T171846Z
DTSTART:20260909T120000Z
DTEND:20260909T130000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Aligos Therapeutics\, Inc. (ALGS) Conference: Cantor Global Healthc
 are Conference
DESCRIPTION:Cantor Global Healthcare Conference\nWebcast: https://investor.
 aligos.com/events/event-details/cantor-global-healthcare-conference
END:VEVENT
END:VCALENDAR